Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $464.0 million.

  • Bristol Myers Squibb's Short-term Investments fell 955.17% to $464.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $464.0 million, marking a year-over-year decrease of 955.17%. This contributed to the annual value of $464.0 million for FY2025, which is 955.17% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Short-term Investments stood at $464.0 million, which was down 955.17% from $776.0 million recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Short-term Investments peaked at $3.0 billion during Q4 2021, and registered a low of $130.0 million during Q4 2022.
  • Its 5-year average for Short-term Investments is $1.1 billion, with a median of $796.0 million in 2023.
  • As far as peak fluctuations go, Bristol Myers Squibb's Short-term Investments crashed by 9564.78% in 2022, and later skyrocketed by 52769.23% in 2023.
  • Bristol Myers Squibb's Short-term Investments (Quarter) stood at $3.0 billion in 2021, then plummeted by 95.65% to $130.0 million in 2022, then soared by 527.69% to $816.0 million in 2023, then crashed by 37.13% to $513.0 million in 2024, then fell by 9.55% to $464.0 million in 2025.
  • Its Short-term Investments stands at $464.0 million for Q4 2025, versus $776.0 million for Q3 2025 and $1.0 billion for Q2 2025.